A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.

The Hallucinogen <i>N,N</i> -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator

Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535 · see citing works

Schizophrenia: A New Approach

Osmond, H., & Smythies, J. (1952) · Journal of Mental Science · doi:10.1192/bjp.98.411.309 · Cited by 474 · see citing works

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · see citing works

Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390 · see citing works

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

McKenna, D. J. (2004) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2004.03.002 · Cited by 321 · see citing works

Dose-Response Study of N,N-Dimethyltryptamine in Humans

Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020009001 · Cited by 291 · see citing works

Human psychopharmacology of N,N-dimethyltryptamine

Strassman, R. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00081-2 · Cited by 261 · see citing works

The globalization of ayahuasca: harm reduction or benefit maximization?

Tupper, K. W. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.11.001 · Cited by 212 · see citing works

Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Obradovic, M., & Kovar, K. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-916185 · Cited by 194 · see citing works

Enzymatic formation of psychotomimetic metabolites from normally occurring compounds

Axelrod, J. (1961) · Science · doi:10.1126/science.134.3475.343 · Cited by 184 · cited 3× · see citing works

Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions

Shen, H.-W., Jiang, X.-L., C. Winter, J., & Yu, A.-M. (2010) · Current Drug Metabolism · doi:10.2174/138920010794233495 · Cited by 170 · see citing works

Drug Tourism or Spiritual Healing? Ayahuasca Seekers in Amazonia

Winkelman, M. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399803 · Cited by 157 · see citing works

DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences

Strassman, R. J. (2000) · UNM’s Digital Repository (University of New Mexico) · Cited by 152 · see citing works

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter

Cozzi, N. V., Gopalakrishnan, A., Anderson, L. L., Feih, J. T., Shulgin, A. T., Daley, P. F., & Ruoho, A. E. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0308-8 · Cited by 144 · see citing works

Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography

Jordi Riba, A., Anderer, P., Jané, F., Saletu, B., & Barbanoj, M. J. (2004) · Neuropsychobiology · doi:10.1159/000077946 · Cited by 130 · see citing works

Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.

Strassman, R. J., Qualls, C. R., & Berg, L. M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00200-6 · Cited by 130 · see citing works

The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine

Gillin, J. C., Kaplan, J., Stillman, R. C., & Wyatt, R. J. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.2.203 · Cited by 123 · see citing works

N,N-Dimethyltryptamine: An Endogenous Hallucinogen

Barker, S. A., Monti, J. A., & Christian, S. T. (1981) · International review of neurobiology · doi:10.1016/s0074-7742(08)60291-3 · Cited by 113 · see citing works

When the Endogenous Hallucinogenic Trace AmineN,N-Dimethyltryptamine Meets the Sigma-1 Receptor

Su, T., Hayashi, T., & Vaupel, D. B. (2009) · Science Signaling · doi:10.1126/scisignal.261pe12 · Cited by 110 · see citing works

DMT: The Spirit Molecule: A Doctor’s Revolutionary Research Into the Biology of Near-Death and Mystical Experiences

HIRSHFELD-FLORES, A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1448 · Cited by 109 · see citing works

The occurrence of amines in human urine: determination by combined ion exchange and paper chromatogrphy

Perry, T. L., & Schroeder, W. A. (1963) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)83697-9 · Cited by 96 · see citing works

Tryptamine, N,N-Dimethyltryptamine, N,N-Dimethyl-5-hydroxytryptamine and 5-Methoxytryptamine in Human Blood and Urine

Franzen, F., & Gross, H. (1965) · Nature · doi:10.1038/2061052a0 · Cited by 88 · see citing works

Human Indolethylamine N-Methyltransferase: cDNA Cloning and Expression, Gene Cloning, and Chromosomal Localization

Thompson, M. A., Moon, E., Kim, U.-J., Xu, J., Siciliano, M. J., & Weinshilboum, R. M. (1999) · Genomics · doi:10.1006/geno.1999.5960 · Cited by 87 · see citing works

Separation and characterization of urinary indoles resembling 5-hydroxytryptamine and tryptamine

Rodnight, R. (1956) · Biochemical Journal · doi:10.1042/bj0640621 · Cited by 81 · see citing works

SEROTONIN AND ITS METHYLATED DERIVATIVES IN HUMAN URINE

Bumpus, F. M., Page, I. H., & Bailey, H. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71098-3 · Cited by 77 · see citing works

In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N,N-dimethyltryptamine in the rat

Sitaram, B. R., Lockett, L., Talomsin, R., Blackman, G. L., & McLeod, W. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90118-3 · Cited by 74 · see citing works

URINARY EXCRETION OF AMINES IN NORMAL CHILDREN

Perry, T. L., Shaw, K. N. F., Walker, D. M., & von Redlich, D. (1962) · PEDIATRICS · doi:10.1542/peds.30.4.576 · Cited by 74 · see citing works

Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates

Barker, S. A., Monti, J. A., & Christian, S. T. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90169-0 · Cited by 70 · see citing works

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

Daumann, J., Wagner, D. R., Heekeren, K., Neukirch, A., Thiel, C. M., & Gouzoulis‐Mayfrank, E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103227 · Cited by 62 · see citing works

Methodology for determining major constituents of ayahuasca and their metabolites in blood

McIlhenny, E. H., Jordi Riba, A., Barbanoj, M. J., Strassman, R. J., & Barker, S. A. (2011) · Biomedical Chromatography · doi:10.1002/bmc.1657 · Cited by 57 · see citing works

A BUFOTENIN-LIKE SUBSTANCE IN THE URINE OF SCHIZOPHRENICS

Fischer, E., FERNANDEZ, T. A., Vázquez, A. J., & STEFANO, A. O. D. (1961) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196111000-00009 · Cited by 56 · see citing works

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine

McIlhenny, E. H., Jordi Riba, A., Barbanoj, M. J., Strassman, R. J., & Barker, S. A. (2010) · Biomedical Chromatography · doi:10.1002/bmc.1551 · Cited by 51 · see citing works

Rabbit Lung Indolethylamine N-Methyltransferase

Thompson, M. A., & Weinshilboum, R. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34502 · Cited by 51 · see citing works

Potentially hallucinogenic 5‐hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues

Kärkkäinen, J., Forsström, T., Tornaeus, J., Wähälä, K., Kiuru, P. S., Honkanen, A., Stenman, U., Turpeinen, U., & Hesso, A. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510013604 · Cited by 50 · see citing works

Hallucinogenic N-Methylated Indolealkylamines in the Cerebrospinal Fluid of Psychiatric and Control Populations

Corbett, L., Christian, S. T., Morin, R. D., Benington, F., & Smythies, J. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.132.2.139 · Cited by 49 · see citing works

Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients

Wyatt, R. J., MANDEL, L. R., Ahn, H. S., Walker, R. W., & Heuvel, W. J. A. V. (1973) · Psychopharmacology · doi:10.1007/bf00422516 · Cited by 49 · see citing works

Detection of Psychotomimetic N,N-Dimethylated Indoleamines in the Urine of Four Schizophrenic Patients

Tanimukai, H., Ginther, R., Spaide, J. K., Bueno, J. R., & Himwich, H. E. (1970) · The British Journal of Psychiatry · doi:10.1192/bjp.117.539.421 · Cited by 49 · see citing works

Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.

Emanuele, E., Colombo, R., Martinelli, V., Brondino, N., Marini, M., Boso, M., Barale, F., & Politi, P. (2010) · PubMed · Cited by 48 · see citing works

Urinary studies of schizophrenics and controls.

Narasimhachari, N., Heller, B., Spaide, J. K., Haskovec, L., Fujimori, M., Tabushi, K., & HIMWICH, H. E. (1971) · PubMed · Cited by 48 · see citing works

N,N-dimethylated indoleamines in blood.

Narasimhachari, N., Heller, B., Spaide, J. K., Haskovec, L., Meltzer, H. Y., Strahilevitz, M., & HIMWICH, H. E. (1971) · PubMed · Cited by 46 · see citing works

Human Hallucinogenic Drug Research in the United States: A Present-day Case History and Review of the Process

Strassman, R. J. (1991) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1991.10472572 · Cited by 43 · see citing works

Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry.

Smythies, Rd, M., & Brown, G. B. (1979) · PubMed · Cited by 43 · see citing works

Dimethyltryptamine levels in blood of schizophrenic patients and control subjects

Angrist, B., Gershon, S., Sathananthan, G., Walker, R. W., Lopez-Ramos, B., MANDEL, L. R., & VandenHeuvel, W. J. A. (1976) · Psychopharmacology · doi:10.1007/bf00428697 · Cited by 43 · see citing works

URINARY INDOLES IN SCHIZOPHRENIC AND PSYCHONEUROTIC PATIENTS AFTER ADMINISTRATION OF TRANYLCYPROMINE (PARNATE) AND METHIONINE OR TRYPTOPHAN

SPRINCE, H., Parker, C. M., Jameson, D., & Alexander, F. (1963) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196309000-00005 · Cited by 43 · see citing works

Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS

T. Forsström, J. T. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101753218319 · Cited by 41 · see citing works

Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine

Räisänen, M., & Kärkkäinen, J. (1979) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81837-x · Cited by 40 · see citing works

Urinary Amines in Chronic Schizophrenia

Perry, T. L., Hansen, S., MacDougall, L., & Schwarz, C. J. (1966) · Nature · doi:10.1038/212146a0 · Cited by 39 · see citing works

Blood dimethyltryptamine concentrations in psychotic disorders.

Lipinski, J. F., MANDEL, L. R., Hs, A., Heuvel, W. J. A. V., & Rw, W. (1974) · PubMed · Cited by 39 · see citing works

Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects

Oon, M. C. H., Murray, R. M., Rodnight, R., Murphy, M. P., & Birley, J. L. T. (1977) · Psychopharmacology · doi:10.1007/bf00426775 · Cited by 38 · see citing works

Increased Excretion of Dimethyltryptamine and Certain Features of Psychosis

Murray, R. M. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780060034003 · Cited by 37 · see citing works

Failure to detect 3,4-Dimethoxyphenylethylamine and Bufotenine in the Urine from a Case of Periodic Catatonia

Nishimura, T., & GJESSING, L. R. (1965) · Nature · doi:10.1038/206963b0 · Cited by 35 · see citing works

Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat

Sitaram, B. R., Lockett, L., Blackman, G. L., & McLeod, W. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90159-6 · Cited by 35 · see citing works

Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma

Walker, R. W., Ahn, H. S., Albers-Schönberg, G., MANDEL, L. R., & VandenHeuvel, W. J. A. (1973) · Biochemical Medicine · doi:10.1016/0006-2944(73)90014-8 · Cited by 33 · see citing works

Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders

Takeda, N., Ikeda, R., Ohba, K., & Kondo, M. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00024 · Cited by 33 · see citing works

Urinary dimethyltryptamine and psychiatric symptomatology and classification

Rodnight, R., Murray, R. M., Oon, M. C. H., Brockington, I., Nicholls, P., & Birley, J. L. T. (1977) · Psychological Medicine · doi:10.1017/s0033291700018304 · Cited by 33 · see citing works

N-dimethylated indoleamines in blood of acute schizophrenics

Heller, B., Narasimhachari, N., Spaide, J. K., Haskovec, L., & Himwich, H. E. (1970) · Cellular and Molecular Life Sciences · doi:10.1007/bf01898472 · Cited by 32 · see citing works

Gas-liquid chromatographic separation and identification of biologically important indolealkylamines from human cerebrospinal fluid

Christian, S. T., Benington, F., Morin, R. D., & Corbett, L. (1975) · Biochemical Medicine · doi:10.1016/0006-2944(75)90036-8 · Cited by 31 · see citing works

A test of the transmethylation hypothesis in acute schizophrenic patients

Carpenter, W. T., Fink, E. B., Narasimhachari, N., & Himwich, H. E. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.10.1067 · Cited by 30 · see citing works

Metabolic Effects of Methionine in Schizophrenic Patients pretreated with a Monoamine Oxidase Inhibitor

Kakimoto, Y., Sano, I., KANAZAWA, A., Tsujio, T., & Kaneko, Z. (1967) · Nature · doi:10.1038/2161110a0 · Cited by 30 · see citing works

A Longitudinal Study of Urinary Excretion of N,N,-Dimethyltryptamine in Psychotic Patients

Checkley, S. A., Murray, R. M., Oon, M. C. H., Rodnight, R., & Birley, J. L. T. (1980) · The British Journal of Psychiatry · doi:10.1192/bjp.137.3.236 · Cited by 30 · see citing works

Observations on the metabolism of the psychotomimetic indolealkylamines: Implications for future clinical studies

Sitaram, B. R., & McLeod, W. R. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90566-k · Cited by 29 · see citing works

Metabolism of bufotenine-2′-14C in human volunteers

Sanders‐Bush, E., Oates, J. A., & Bush, M. T. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90441-0 · Cited by 28 · see citing works

A biochemical study of early infantile autism

Himwich, H. E., Jenkins, R. L., Fujimori, M., Narasimhachari, N., & Ebersole, M. (1972) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01537565 · Cited by 28 · see citing works

Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring

Narasimhachari, N., & Himwich, H. E. (1973) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(73)80003-8 · Cited by 28 · see citing works

A senstive method for the detection of N, N-dimethylserotonin (bufotenin) in urine; failure to demonstrate its presence in the urine of schizophrenic and normal subjects

Siegel, M. (1965) · Journal of Psychiatric Research · doi:10.1016/0022-3956(65)90030-0 · Cited by 28 · see citing works

Studies on urinary elimination of bufotenine-like substances in schizophrenia.

Fischer, E., & Spatz, H. (1970) · PubMed · Cited by 28 · see citing works

Psychotomimetic Indole Compound in the Urine of Schizophrenics and Mentally Defective Patients

Tanimukai, H., Ginther, R., Spaide, J. K., & Himwich, H. E. (1967) · Nature · doi:10.1038/216490a0 · Cited by 27 · see citing works

A gas chromatographic procedure for determining N, N-dimethyltryptamine and N-monomethyltryptamine in urine using a nitrogen detector

Oon, M. C. H., & Rodnight, R. (1977) · Biochemical Medicine · doi:10.1016/0006-2944(77)90077-1 · Cited by 27 · see citing works

N -Methylmetanephrine: Excretion by Juvenile Psychotics

Perry, T. L. (1963) · Science · doi:10.1126/science.139.3555.587 · Cited by 27 · see citing works

Improved selective ion monitoring mass-spectrometric assay for the determination of n,n-dimethyltryptamine in human blood utilizing capillary column gas chromatography

Walker, R. W., MANDEL, L. R., Kleinman, J. E., Gillin, J. C., Wyatt, R. J., & VandenHeuvel, W. J. A. (1979) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81833-2 · Cited by 26 · see citing works

BLOOD AND URINARY DIMETHYLTRYPTAMINE IN ACUTE PSYCHOTIC DISORDERS

Bidder, T. G., MANDEL, L. R., Ahn, H. S., VandenHeuvel, W. J. A., & Walker, R. W. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92455-6 · Cited by 25 · see citing works

BUFOTENIN IN HUMAN URINE

FISCHER, E. (1961) · The Lancet · doi:10.1016/s0140-6736(61)90220-3 · Cited by 24 · see citing works

Studies of drug-free schizophrenics and controls.

Narasimhachari, N., Avalos, J., Fujimori, M., & HIMWICH, H. E. (1973) · PubMed · Cited by 23 · see citing works

DMT at fifty.

Szara, S. I. (2007) · PubMed · Cited by 22 · see citing works

Phenolic and Indole Amines in the Urine of Schizophrenics

Takesada, M., Miyamoto, E., Kakimoto, Y., Sano, I., & Kaneko, Z. (1965) · Nature · doi:10.1038/2071199b0 · Cited by 22 · see citing works

Occurrence of bufotenin (5-hydroxy-N, N-dimethyltryptamine) in urine of schizophrenic patients

Tanimukai, H., Ginther, R., Spaide, J. K., Bueno, J., & Himwich, H. E. (1967) · Life Sciences · doi:10.1016/0024-3205(67)90138-5 · Cited by 22 · see citing works

INCREASED URINARY EXCRETION OF BUFOTENIN BY VIOLENT OFFENDERS WITH PARANOID SYMPTOMS AND FAMILY VIOLENCE

Räisänen, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91263-7 · Cited by 21 · see citing works

URINARY EXCRETION OF BUFOTENIN-LIKE SUBSTANCE IN PSYCHOTIC PATIENTS.

Gg, B., Hh, H., & HIMWICH, H. E. (1963) · PubMed · Cited by 21 · see citing works

Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography.

Riceberg, L. J., & Vunakis, H. V. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31309-1 · Cited by 20 · see citing works

Urinary Excretion of Dimethyltryptamine in Liver Disease

Checkley, S. A., Oon, M. C. H., Rodnight, R., Murphy, M. P., Williams, R. L., & Birley, J. L. T. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.1979.136.4a.439 · Cited by 20 · see citing works

Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.

Narasimhachari, N., Baumann, P., Pak, H. S., Carpenter, W. T., Zocchi, A. F., Hokanson, L., Fujimori, M., & Himwich, H. E. (1974) · PubMed · Cited by 19 · see citing works

SEARCH FOR A BUFOTENIN-LIKE SUBSTANCE IN THE URINE OF SCHIZOPHRENICS

Runge, T. M., LARA, F. Y., Thurman, N., KEYES, J. W., & HOERSTER, S. H. (1966) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196605000-00011 · Cited by 17 · see citing works

The ion-pair extraction, purification, and liquid chromatographic analysis of indolealkylamines in human urine

Sitaram, B. R., Blackman, G. L., McLeod, W. R., & Vaughan, G. N. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90337-8 · Cited by 17 · see citing works

Radioactive Serotonin in Relation to Schizophrenia

Feldstein, A. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710150028005 · Cited by 17 · see citing works

A bufotenin-like substance in the urine of schizophrenics

Cottrell, A. C., McLeod, M. F., & McLeod, W. R. (1977) · American Journal of Psychiatry · doi:10.1176/ajp.134.3.322 · Cited by 17 · see citing works

Modifications papar and thin layer chromatographic methods to increase sensitivity for detecting N-methylated indoleamines in urine.

Tanimukai, H. (1967) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)84125-4 · Cited by 16 · see citing works

Urinary excretion of bufotenin (N,N-dimethyl-5-hydroxytryptamine) is increased in suspicious violent offenders: A confirmatory study

Kärkkäinen, J., Räisänen, M., HUTTUNEN, M. O., Kallio, E., Naukkarinen, H., & Virkkunen, M. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02747-k · Cited by 16 · see citing works

Urinary excretion of free bufotenin by psychiatric patients

Kärkkäinen, J., Räisänen, M., Naukkarinen, H., Spoov, J., & Rimón, R. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90182-5 · Cited by 14 · see citing works

Occurrence of Bufotenin in the Urine of Schizophrenic Patients and Normal Persons

Faurbye, A., & Pind, K. (1968) · Nature · doi:10.1038/220489a0 · Cited by 14 · see citing works

Biochemical studies in early infantile autism.

Narasimhachari, N., & HIMWICH, H. E. (1975) · PubMed · Cited by 13 · see citing works

Bufotenin Like Substances in Form of Glucuronide in Schizophrenic and Normal Urines

Fischer, E., Spatz, H., & Fledel, T. (1971) · Psychosomatics · doi:10.1016/s0033-3182(71)71520-5 · Cited by 11 · see citing works

Halogenated solvent interactions with N,N-dimethyltryptamine: Formation of quaternary ammonium salts and their artificially induced rearrangements during analysis

Brandt, S. D., Martins, C. P. B., Freeman, S., Dempster, N. M., Riby, P. G., Gartz, J., & Alder, J. F. (2008) · Forensic Science International · doi:10.1016/j.forsciint.2008.03.013 · Cited by 10 · see citing works

Quantitative Assay of Bufotenine in Psychiatric Outpatients

Saavedra, J. M., & Udabe, U. (1970) · Psychosomatics · doi:10.1016/s0033-3182(70)71667-8 · Cited by 10 · see citing works

Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.

Heller, B. (1966) · PubMed · Cited by 10 · see citing works

Determination of bufotenin in the urine of schizophrenics.

Fischer, E., & Spatz, H. (1967) · PubMed · Cited by 8 · see citing works

Nialamide, an MAO inhibitor, increases urinary excretion of endogenously produced bufotenin in man

Kärkkäinen, J., & Räisänen, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90066-9 · Cited by 7 · see citing works

Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.

Gillin, J. C., & Wyatt, R. J. (1976) · PubMed · Cited by 7 · see citing works

Urinary Excretion of N,N-Dimethylated Tryptamines in Chronic Schizophrenia: A Review of the Present Status of the Hypothesis

Huszka, L., Zabek, D. H., & Doust, J. W. L. (1976) · Canadian Psychiatric Association Journal · doi:10.1177/070674377602100808 · Cited by 6 · see citing works

Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.

Acebal, E. M., & Spatz, H. (1967) · PubMed · Cited by 4 · see citing works

Studies on the elimination of bufotenin in urine.

Dw, S., & Marini, F. A. (1969) · PubMed · Cited by 3 · see citing works

Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of change.

Pecknold, J. C., Ban, T. A., & Lehmann, H. E. (1976) · PubMed · Cited by 3 · see citing works

Laboratory and animal studies on the chemistry of bufotenin. Quantitative determination on bufotenin in human urine.

Spatz, H., Dw, S., Marini, F. A., Fischer, E., Bonhour, A., & Acebal, E. M. (1969) · PubMed · Cited by 3 · see citing works

The Excretion of Dimethyltryptamine in Psychiatric Patients

Murray, R. M., & Oon, M. C. H. (1976) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577606901122 · Cited by 2 · see citing works

Serotonin and brain function: a tale of two receptors

Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · see citing works

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., et al. (2023) · Science · doi:10.1126/science.adf0435 · Cited by 494 · see citing works

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F. D., Bastos, M. D. L., de Pinho, P. G., & Carvalho, M. C. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1513-x · Cited by 292 · see citing works

Neuropharmacology of N,N-dimethyltryptamine

Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268 · see citing works

The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization

Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242 · see citing works

Clinical applications of hallucinogens: a review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201 · see citing works

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function

Barker, S. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00536 · Cited by 177 · see citing works

Effects of <i>N</i>,<i>N</i>-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression

Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00134 · Cited by 171 · see citing works

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

SANTOS, R. G. D., Bouso, J. C., & Hallak, J. E. C. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316689030 · Cited by 168 · see citing works

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

Szabo, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00358 · Cited by 150 · see citing works

Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT

Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. D. M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12779-5 · Cited by 134 · see citing works

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases

Penke, B., Fülöp, L., Szűcs, M., & Frecska, E. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170529104323 · Cited by 132 · see citing works

Toxicokinetics and Toxicodynamics of Ayahuasca alkaloids N,N-dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: clinical and forensic impact

Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2020) · Pharmaceuticals · doi:10.3390/ph13110334 · Cited by 117 · see citing works

Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT)

Cameron, L. P., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00101 · Cited by 117 · see citing works

Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain

Dean, J. G., Liu, T., Huff, S., Sheler, B., Barker, S. A., Strassman, R. J., Wang, M. M., & Borjigin, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45812-w · Cited by 107 · see citing works

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Frecska, E., Szabo, A., Winkelman, M. J., Luna, L. E., & McKenna, D. J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1024-y · Cited by 109 · see citing works

Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports

Martial, C., Cassol, H., Charland‐Verville, V., Pallavicini, C., Sanz, C., Zamberlán, F., Vivot, R. M., Erowid, F., Erowid, E., Laureys, S., et al. (2019) · Consciousness and Cognition · doi:10.1016/j.concog.2019.01.011 · Cited by 102 · see citing works

Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study

Jordi Riba, A., McIlhenny, E. H., Bouso, J. C., & Barker, S. A. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1685 · Cited by 98 · see citing works

A narrative synthesis of research with 5-MeO-DMT

Ermakova, A. O., Dunbar, F., Rucker, J., & Johnson, M. W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211050543 · Cited by 90 · see citing works

Serotonin 2A Receptor (5-HT 2A R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants

Duan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 79 · see citing works

DMT alters cortical travelling waves

Alamia, A., Timmermann, C., Nutt, D. J., VanRullen, R., & Carhart-Harris, R. L. (2020) · eLife · doi:10.7554/elife.59784 · Cited by 97 · see citing works

N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain

Szabó, Í., Varga, V. É., Dvorácskó, S., Farkas, A. E., Körmöczi, T., Berkecz, R., Kecskés, S., Menyhárt, Á., Frank, R., Hantosi, D., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108612 · Cited by 72 · see citing works

LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate.

Barker, S. A., Borjigin, J., Lomnicka, I., & Strassman, R. (2013) · Biomedical Chromatography · doi:10.1002/bmc.2981 · Cited by 72 · see citing works

Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms

Li, J., Sun, C., Cai, W., Li, J., Rosen, B. P., & Chen, J. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108396 · Cited by 68 · see citing works

<i>N,N</i> -dimethyltryptamine and the pineal gland: Separating fact from myth

Nichols, D. E. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117736919 · Cited by 69 · see citing works

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT

Barker, S. A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06065-0 · Cited by 58 · see citing works

Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience

SANTOS, R. G. D., & Hallak, J. E. C. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.04.053 · Cited by 56 · see citing works

Noncompetitive Inhibition of Indolethylamine- N -methyltransferase by N , N -Dimethyltryptamine and N , N -Dimethylaminopropyltryptamine

Chu, U. B., Vorperian, S. K., Satyshur, K. A., Eickstaedt, K., Cozzi, N. V., Mavlyutov, T. A., Hajipour, A. R., & Ruoho, A. E. (2014) · Biochemistry · doi:10.1021/bi500175p · Cited by 54 · see citing works

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Gallimore, A. R., & Strassman, R. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00211 · Cited by 53 · see citing works

Exploring DMT: Endogenous role and therapeutic potential

Schimmelpfennig, J., & Jankowiak-Siuda, K. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110314 · Cited by 54 · see citing works

Psychoactive natural products: overview of recent developments.

Ujváry, I. (2014) · PubMed · doi:10.4415/ann_14_01_04 · Cited by 48 · see citing works

An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study

Michael, P., Luke, D. P., & Robinson, O. C. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.720717 · Cited by 46 · see citing works

N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine

James, E., Keppler, J., Robertshaw, T. L., & Sessa, B. (2022) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2835 · Cited by 43 · see citing works

Ayahuasca as a Candidate Therapy for PTSD

Nielson, J. L., & Megler, J. D. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_3 · Cited by 40 · see citing works

A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches

Meyer, M. R., Caspar, A. T., Brandt, S. D., & Maurer, H. H. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7425-9 · Cited by 39 · see citing works

Psychoactive Substances and Paranormal Phenomena: A Comprehensive Review

Luke, D. P. (2012) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2012.31.1.97 · Cited by 38 · see citing works

Pineal gland and schizophrenia: A systematic review and meta-analysis

Bastos, M. A. V., Bastos, P. R. H. D. O., Portella, R. B., Soares, L. F. G., Conde, R. B., Rodrigues, P. M. F., & Lucchetti, G. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.024 · Cited by 35 · see citing works

Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks

Gaujac, A., Martinez, S. T., Gomes, A. A., de Andrade, S. J., Pinto, Â. D. C., David, J. M., Navickiene, S., & de Andrade, J. B. (2012) · Microchemical Journal · doi:10.1016/j.microc.2012.03.033 · Cited by 35 · see citing works

Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate

Jiménez, J. H., & Bouso, J. C. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104054 · Cited by 37 · see citing works

Nationwide investigation on the use of new psychoactive substances in Italy through urban wastewater analysis

Salgueiro‐González, N., Zuccato, E., & Castiglioni, S. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156982 · Cited by 34 · see citing works

Analytical techniques for the determination of tryptamines and β‐carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo‐shamanic urban practices

Gaujac, A., Navickiene, S., Collins, M. I., Brandt, S. D., & de Andrade, J. B. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1343 · Cited by 34 · see citing works

Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine

Dean, J. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00232 · Cited by 37 · see citing works

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder

Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. (2018) · Progress in Brain Research · doi:10.1016/bs.pbr.2018.08.002 · Cited by 38 · see citing works

The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity

Gupta, S., Bhatnagar, R. K., Gupta, D., Maharaj Kumari, K., & Chopra, A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06777-z · Cited by 30 · see citing works

Ayahuasca and cancer treatment

Schenberg, E. E. (2013) · SAGE Open Medicine · doi:10.1177/2050312113508389 · Cited by 30 · see citing works

New Paradigms of Old Psychedelics in Schizophrenia

Mahmood, D., Alenezi, S. K., Anwar, M. J., Azam, F., Qureshi, K. A., & Jaremko, M. (2022) · Pharmaceuticals · doi:10.3390/ph15050640 · Cited by 29 · see citing works

Dimethyltryptamine: Endogenous Role and Therapeutic Potential

Rodrigues, A. V., Almeida, F., & Vieira‐Coelho, M. A. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1602291 · Cited by 30 · see citing works

Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status

Jiang, X.-L., Shen, H.-W., Mager, D. E., & Yu, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050724 · Cited by 29 · see citing works

On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis

Grammenos, D., & Barker, S. A. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1329-5 · Cited by 28 · see citing works

Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry

Kanu, A. B., Brandt, S. D., Williams, M., Zhang, N., & Hill, H. H. (2013) · Analytical Chemistry · doi:10.1021/ac401951a · Cited by 28 · see citing works

N,N-Dimethyltryptamine–Induced Psychosis

Paterson, N. E., Darby, W. C., & Sandhu, P. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000078 · Cited by 26 · see citing works

A neuroscientific model of near-death experiences

Martial, C., Fritz, P., Gosseries, O., Bonhomme, V. L., Kondziella, D., Nelson, K. R., & Lejeune, N. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01072-z · Cited by 30 · see citing works

DMT alters cortical travelling wavesPreprint

Alamia, A., Timmermann, C., VanRullen, R., & Carhart-Harris, R. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.06.080937 · Cited by 25 · see citing works

Risk assessment of dietary exposure to tryptamine for the Austrian population

Wüst, N., Rauscher‐Gabernig, E., Steinwider, J., Bauer, F., & Paulsen, P. (2016) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2016.1269207 · Cited by 24 · see citing works

Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS

Bambauer, T. P., Wagmann, L., Maurer, H. H., Weber, A. A., & Meyer, M. R. (2020) · Talanta · doi:10.1016/j.talanta.2020.120847 · Cited by 22 · see citing works

Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases

Gomes, M. M., Coimbra, J. B., Clara, R. O., Dörr, F. A., Moreno, A. C. R., Chagas, J. R., Tufik, S., Pinto, E., Catalani, L. H., & Čampa, A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.035 · Cited by 22 · see citing works

Base-mediated chalcogenoaminative annulation of 2-alkynylanilines for direct access to 3-sulfenyl/selenyl-1 H -indoles

Chen, W.-C., Bai, R., Cheng, W.-L., Peng, C.-Y., Reddy, D. M., Badsara, S. S., & Lee, C. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob00279a · Cited by 21 · see citing works

Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders

Shomrat, T., & Nesher, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00037 · Cited by 22 · see citing works

An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study

Michael, P., Luke, D. P., & Robinson, O. C. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1083356 · Cited by 19 · see citing works

Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics

Campanale, A., Inserra, A., & Comai, S. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111058 · Cited by 18 · see citing works

Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines

Grafinger, K. E., Wilke, A., König, S., & Weinmann, W. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2544 · Cited by 17 · see citing works

Further development of a liquid chromatography–high‐resolution mass spectrometry/mass spectrometry‐based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions

Bambauer, T. P., Wagmann, L., Weber, A. A., & Meyer, M. R. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3106 · Cited by 17 · see citing works

Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats

Glynos, N. G., Carter, L., Lee, S. J., Kim, Y., Kennedy, R. T., Mashour, G. A., Wang, M. M., & Borjigin, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-27538-y · Cited by 17 · see citing works

Ayahuasca: what mental health professionals need to know

SANTOS, R. G. D., Bouso, J. C., & Hallak, J. E. C. (2017) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000130 · Cited by 16 · see citing works

Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application

Körmöczi, T., Szabó, Í., Farkas, E., Penke, B., Janáky, T., Ilisz, I., & Berkecz, R. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113615 · Cited by 16 · see citing works

The Antidepressant Effects of Vaporized N , N -Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression

Falchi-Carvalho, M., Barros, H., Bolcont, R., Laborde, S., Wießner, I., Silva, S. R. B., Montanini, D., Barbosa, D. C., Teixeira, E., Florence-Vilela, R., et al. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2024.0002 · Cited by 15 · see citing works

Ayahuasca: Pharmacology, Safety, and Therapeutic Effects

SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009585330.005 · Cited by 18 · see citing works

QEEG studies of the acute effects of the visionary tryptamine DMT.

Acosta‐Urquidi, J. (2015) · Cosmos and history · doi:10.13140/rg.2.1.4069.4248 · Cited by 15 · see citing works

Alkaloids: Their relevance in cancer treatment

Varela, C. L., Silva, F., Costa, G., & Cabral, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99873-4.00006-2 · Cited by 14 · see citing works

Psychedelic Therapy: A Primer for Primary Care Clinicians—N,N-Dimethyltryptamine and Ayahuasca

Shinozuka, K., Tabaac, B. J., Arenas, A., Beutler, B. D., Cherian, K. N., Evans, V. D., Fasano, C., & Muir, O. S. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001725 · Cited by 15 · see citing works

Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy- N , N -dimethyltryptamine Analogs in Mice

Glatfelter, G. C., Clark, A. A., Cavalco, N. G., Landavazo, A., Partilla, J. S., Naeem, M., Golen, J. A., Chadeayne, A. R., Manke, D. R., Blough, B. E., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00513 · Cited by 14 · see citing works

Neurochemical and Neurophysiological Effects of Intravenous Administration of N,N -Dimethyltryptamine in Rats

Glynos, N. G., Huels, E. R., Groenhout, T., Raghu, A., Nelson, A. G., Kim, Y., Zeid, A. M., Liu, T., Mashour, G. A., Kennedy, R. T., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0742-24.2025 · Cited by 15 · see citing works

Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca

Liu, M., Yang, H., Hu, J., Shen, B., Xiang, P., Qiang, H., Deng, H., Yu, Z., & Shi, Y. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110790 · Cited by 14 · see citing works

A Sideways Look at the Neurobiology of Psi: Precognition and Circadian Rhythms

Luke, D. P., Zychowicz, K., Richterova, O., Tjurina, I., & Polonnikova, J. (2012) · NeuroQuantology · doi:10.14704/nq.2012.10.3.614 · Cited by 13 · see citing works

Long-lasting analgesic effect of the psychedelic drug changa: A case report

Oña, G., & Troncoso, S. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.001 · Cited by 12 · see citing works

Quantum chemical (QM:MM) investigation of the mechanism of enzymatic reaction of tryptamine and N , N -dimethyltryptamine with monoamine oxidase A

Kubicskó, K., & Farkas, Ö. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01118e · Cited by 12 · see citing works

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Chaves, C., SANTOS, R. G. D., Dursun, S. M., Tusconi, M., Carta, M. G., Brietzke, E. M., & Hallak, J. E. C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1485337 · Cited by 11 · see citing works

The Association between the Urinary Excretion of Trimethylselenonium and Trimethylsulfonium in Humans

Lajin, B., & Francesconi, K. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167013 · Cited by 11 · see citing works

Physiologic correlates of culture-bound dissociation: A comparative study of Brazilian spiritist mediums and controls

Bastos, M. A. V., Bastos, P. R. H. D. O., Osório, I. H. S., Pinheiro, S. A. M., Iandoli, D., & Lucchetti, G. (2018) · Transcultural Psychiatry · doi:10.1177/1363461518759202 · Cited by 11 · see citing works

Internet method for the extraction of N,N-dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine?

Rossi, G. N., Crevelin, E. J., Silveira, G. D. O., Queiroz, M. E. C., Yonamine, M., Hallak, J. E. C., & SANTOS, R. G. D. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.009 · Cited by 10 · see citing works

Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry

Gaujac, A., Ford, J. L., Dempster, N. M., de Andrade, J. B., & Brandt, S. D. (2013) · Microchemical Journal · doi:10.1016/j.microc.2013.03.009 · Cited by 10 · see citing works

Sensors for the Detection of Illicit Drugs

Purohit, S., Pandey, G., Tharmavaram, M., Rawtani, D., & Hussain, C. M. (2020) · doi:10.1002/9783527827688.ch11 · Cited by 10 · see citing works

Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics

Sadée, W. (2023) · Molecules · doi:10.3390/molecules28176375 · Cited by 9 · see citing works

Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans

Barman, R., Bora, P. K., Saikia, J., Konwar, P., Sarkar, A., Kemprai, P., Saikia, S. P., Haldar, S., Slater, R. J., & Banik, D. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113928 · Cited by 9 · see citing works

Detailed resume of S-methyltransferases: Categories, structures, biological functions and research advancements in related pathophysiology and pharmacotherapy

Mu, H., Ye, L., & Wang, B. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116361 · Cited by 8 · see citing works

Research on psychedelic substances

Brandt, S. D., & Passie, T. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1389 · Cited by 8 · see citing works

Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT)

Witowski, C. G., Hess, M. R., Jones, N., Pellitteri-Hahn, M. C., Razidlo, J. A., Bhavsar, R., Beer, C., Gonzalez-Velazquez, N. M., Scarlett, C. O., Wenthur, C. J., et al. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106803 · Cited by 7 · see citing works

Mining and Characterization of Indolethylamine N-Methyltransferases in Amphibian Toad Bufo gargarizans

Zhang, A.-A., He, Q., & Zhao, Q. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00229 · Cited by 7 · see citing works

Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography–tandem mass spectrometry

Wood, M. E., Brown, G. J., Karschner, E. L., Seither, J. Z., Brown, J. T., Knittel, J. L., & Walterscheid, J. P. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae002 · Cited by 6 · see citing works

Comparing the Detection of Endogenous Psychedelics in Individuals With and Without Alleged Mediumistic Experiences

Bastos, M. A. V., Bastos, P. R. H. D. O., dos Santos, M. L., Iandoli, D., Portella, R. B., & Lucchetti, G. (2018) · EXPLORE · doi:10.1016/j.explore.2018.04.013 · Cited by 6 · see citing works

Rapid, Open-Source, and Automated Quantification of the Head Twitch Response in C57BL/6J Mice Using DeepLabCut and Simple Behavioral Analysis

Maitland, A. D., Gonzalez, N. R., Walther, D. M., Pereira, F. L. F., Baumann, M. H., & Glatfelter, G. C. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00305 · Cited by 5 · see citing works

N -Methylserotonin hydrogen oxalate

Naeem, M., Anas, N. A., Chadeayne, A. R., Golen, J. A., & Manke, D. R. (2023) · IUCrData · doi:10.1107/s2414314623003784 · Cited by 5 · see citing works

On the advances in machine learning and complex network measures to an EEG dataset from DMT experiments

Alves, C. L., Ciba, M., Toutain, T. G. L. D. O., Porto, J. A. M., de Sena, E. P., Thielemann, C., & Rodrigues, F. A. (2024) · Journal of Physics Complexity · doi:10.1088/2632-072x/ad1c68 · Cited by 4 · see citing works

Introduction to the chemistry and pharmacology of psychedelic drugs

Walker, S. R., Pullella, G. A., Piggott, M., & Duggan, P. J. (2023) · Australian Journal of Chemistry · doi:10.1071/ch23050 · Cited by 5 · see citing works

Tryptamines

Greene, S. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818788-3.00014-0 · Cited by 5 · see citing works

N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data

Barker, S. A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111259 · Cited by 4 · see citing works

Analysis of N,N‐dimethyltryptamine ( DMT ) and its metabolites using LC – MS / MS for forensic purposes

Gomonit, M. M., Swortwood, M. J., Truver, M. T., & Skillman, B. N. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70013 · Cited by 4 · see citing works

Hyperespace dans le cyberespace : DMT et méta-ritualisation

John, G. S. (2017) · Drogues santé et société · doi:10.7202/1041854ar · Cited by 4 · see citing works

N,N-dimethyltryptamine facts and myths

Barker, S. A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118767648 · Cited by 4 · see citing works

An encounter with death: a comparative thematic and content analysis of naturalistic DMT experiences and the near-death experience

Michael, P., Luke, D. P., & Robinson, O. C. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1532937 · Cited by 4 · see citing works

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function

Barker, S. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00536 · Cited by 177 · see citing works

A SYSTEMATIC REVIEW OF RESEARCH ON N,N-DIMETHYLTRYPTAMINE

Hristova, D. M., & Zhelyazkova-Savova, M. (2017) · Scripta Scientifica Vox Studentium · doi:10.14748/ssvs.v1i1.2700

Dimethyltryptamine: Endogenous Role and Therapeutic Potential

Rodrigues, A. V., Almeida, F., & Vieira‐Coelho, M. A. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1602291 · Cited by 30 · see citing works

DMT (N,N-DIMETHYLTRYPTAMINE) AND HOMOLOGUES: CLINICAL AND PHARMACOLOGICAL CONSIDERATIONS

D, S. S. M., Dose, J.-I. P. C., & Ri, R. (2015)

Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT)

Cameron, L. P., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00101 · Cited by 117 · see citing works